Long acting growth hormone (LAGH), an update
In 1957, Maurice Raben at Yale was able to isolate and purify growth hormone from cadaveric pituitary glands. Pituitary growth hormone was the only way to treat children with growth hormone (GH) deficiency, until 1985 when recombinant GH became available for daily subcutaneous injection. For many ye...
Main Authors: | Margaret Steiner Grillo, Jacklyn Frank, Paul Saenger |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-09-01
|
Series: | Frontiers in Pediatrics |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fped.2023.1254231/full |
Similar Items
-
Long‐acting growth hormone in 2022
by: Margaret Steiner, et al.
Published: (2023-03-01) -
Long-acting growth hormone in the treatment of growth hormone deficiency in children: a systematic literature review and network meta-analysis
by: Jianfang Zhu, et al.
Published: (2024-04-01) -
Usefulness and Potential Pitfalls of Long-Acting Growth Hormone Analogs
by: Kevin C. J. Yuen, et al.
Published: (2021-02-01) -
Corrigendum: Usefulness and Potential Pitfalls of Long-Acting Growth Hormone Analogues
by: Kevin C. J. Yuen, et al.
Published: (2021-06-01) -
Efficacy, safety, quality of life, adherence and cost-effectiveness of long-acting growth hormone replacement therapy compared to daily growth hormone in children with growth hormone deficiency: A systematic review and meta-analysis
by: Chiara Mameli, et al.
Published: (2023-07-01)